explore -WSS

explore

author：explore 2025-10-02 18:48:17 - browse：9

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The Sacklers, horror, and ‘The Fall of the House of Usher’

WSS

Medicare solvency divides Republicans at the presidential debate

FDA approves Recor Medical high blood pressure device

Vertex non

Removing probiotics from the NICU could threaten preemies' health

Senate panel clears PBM, hopsital reforms

FTC sues over Novant Health acquisition of two N.C. hospitals

explore

explore

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Medical records are filled with copy

Venture capital firm's plans to take over Akron hospital face hurdles

In age of alternative facts, a scholarly course on calling out crap

Removing probiotics from the NICU could threaten preemies' health

In Memoriam: Notable people who died in 2023

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Malaria cases in Florida and Texas: Here’s what you need to know

Wegovy leads to weight loss. Can it treat depression, too?

Anesthesiologist group: stop taking Ozempic before surgery

New clues to why women have higher risk of autoimmune disorders

knowledge

10 million people disenrolled from Medicaid over past six months

Venture capital firm's plans to take over Akron hospital face hurdles

FDA approves Recor Medical high blood pressure device

Readout Newsletter: The latest on Novavax, Merck, Bluebird

More doctors should go into startup world

Merck CEO won’t testify in Senate, citing no expertise in drug prices

explore

hotspot

focus

entertainment